FDA Finds Drug Missing Main Ingredient in Random Testing

Posted on

The Food and Drug Administration has banned the use of a particular batch of the drug Frusemide, used as a diuretic, after finding a batch was missing the main ingredient during random testing, according to news sources.

The drug, which is used in patients with liver, kidney, and heart problems, was found to have defects in batches used in state government hospitals in Maharashtra, but not any private hospitals or drug stores.

The FDA has filed a lawsuit against Endolabs Ltd, the manufacturer. Of the 100 tablets that the FDA ran tests on, 70 percent did not have the ingredient in them, while 30 percent only had 69.5 percent of the ingredient.

The FDA will also continue to test other batches as a precautionary measure.

As a Los Angeles product defect lawyer, I always encourage anyone taking a drug to thoroughly examine their medication. It is not unheard of for drugs to be mislabeled. Even with all of the safety procedures in place to make sure nothing goes wrong, sometimes it does, and sometimes drugs are tampered with by outside parties. Please make sure your medication matches the description physically, and contact your physician if you begin experiencing odd or unexpected side effects. If you have taken a drug and were not made aware of the side effect, you can call a personal injury lawyer at our office at any time. If you’ve experienced pain and suffering, we are here to help you.